- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Bionomics is a biotechnology business based in the US. Bionomics shares (BNOX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.24 – a decrease of 24.82% over the previous week. Bionomics employs 8 staff and has a trailing 12-month revenue of around $661,980.
Our top picks for where to buy Bionomics Ltd ADR stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Bionomics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BNOX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Bionomics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Bionomics stock price (NASDAQ: BNOX)
Use our graph to track the performance of BNOX stocks over time.Bionomics shares at a glance
Information last updated 2024-12-19.
| Latest market close | $0.24 |
|---|---|
| 52-week range | $0.18 - $1.60 |
| 50-day moving average | $0.29 |
| 200-day moving average | $0.67 |
| Wall St. target price | $9.59 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.19 |
Is it a good time to buy Bionomics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bionomics price performance over time
Historical closes compared with the close of $0.2429 from 2024-12-20
| 1 week (2024-12-13) | -24.82% |
|---|---|
| 1 month (2024-11-22) | -17.55% |
| 3 months (2024-09-20) | -60.82% |
| 6 months (2024-06-21) | -68.48% |
| 1 year (2023-12-22) | -81.46% |
|---|---|
| 2 years (2022-12-22) | -94.84% |
| 3 years (2021-12-22) | 12.4 |
| 5 years (2019-12-18) | N/A |
Bionomics financials
| Revenue TTM | $661,980 |
|---|---|
| Operating margin TTM | 8909.69% |
| Gross profit TTM | $-18,963,665 |
| Return on assets TTM | -39.58% |
| Return on equity TTM | -78.44% |
| Profit margin | 0% |
| Book value | $1.32 |
| Market Capitalization | $5.1 million |
TTM: trailing 12 months
Bionomics share dividends
We're not expecting Bionomics to pay a dividend over the next 12 months.
You may also wish to consider:
- Merck-and-Company (MRK.US) (3.29% forward annual dividend yield)
- Johnson-and-Johnson (JNJ.US) (3.43% forward annual dividend yield)
- UnitedHealth Group Incorporated (UNH.US) (1.68% forward annual dividend yield)
Bionomics share price volatility
Over the last 12 months, Bionomics's shares have ranged in value from as little as $0.177 up to $1.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bionomics's is -0.069. This would suggest that Bionomics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Bionomics has bucked the trend.
To put Bionomics's beta into context you can compare it against those of similar companies.
- Merck-and-Company (MRK.US): 0.411
- Johnson-and-Johnson (JNJ.US): 0.518
- UnitedHealth Group Incorporated (UNH.US): 0.591
Bionomics overview
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7, which is in phase 3 clinical trial for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress disorder. The company also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. In addition, it develops NextGen, which is in preclinical trial for the treatment of multiple central nervous system indications; Kv3. 1/3. 2 agonist, which is in preclinical trial to treat potential cognitive deficits and negative symptoms/social withdrawal in schizophrenia and autism spectrum disorders; and Nav1. 7/1.
Frequently asked questions
What percentage of Bionomics is owned by insiders or institutions?Currently 33.911% of Bionomics shares are held by insiders and 16.221% by institutions. How many people work for Bionomics?
Latest data suggests 8 work at Bionomics. When does the fiscal year end for Bionomics?
Bionomics's fiscal year ends in June. Where is Bionomics based?
Bionomics's address is: 200 Greenhill Road, Eastwood, SA, Australia, 5063 What is Bionomics's ISIN number?
Bionomics's international securities identification number is: US09063M2052
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question